Roflumilast is an anti-inflammatory medication specifically indicated for patients with severe chronic obstructive pulmonary disease (COPD). By inhibiting the PDE4 enzyme, it helps reduce lung inflammation and prevent the worsening of symptoms. It serves as the active ingredient in quality generic treatments for respiratory health. Our platform facilitates the purchase of verified medications containing Roflumilast, providing a dependable source for your ongoing COPD management.
Roflumilast belongs to a class of medicines known as phosphodiesterase-4 (PDE4) inhibitors. It is designed to reduce inflammation inside the airways, helping the lungs work more efficiently. In the UK, roflumilast is available as the brand-name product Daliresp and also as a generic preparation simply called roflumilast.
The two main products that contain roflumilast are:
Both are supplied as oral tablets, typically in a 500 µg strength, although the exact dosage may vary between brands. The tablets are taken whole with water. Availability across the United Kingdom follows standard NHS prescribing channels, and both brand and generic versions are listed on the British National Formulary.
Roflumilast is primarily used in the management of chronic obstructive pulmonary disease (COPD). It is prescribed for patients with severe COPD who continue to experience frequent flare-ups despite receiving standard inhaled therapies. By lowering airway inflammation, roflumilast helps to:
Although its main indication is COPD, clinicians may consider roflumilast for other inflammatory lung conditions when appropriate, always following national guidance.
Roflumilast blocks the activity of the enzyme PDE4, which is involved in the inflammatory process inside the lungs. By inhibiting this enzyme, the drug decreases the release of inflammatory cells and substances that narrow the airways. The effect begins within a few days of starting treatment, but the full benefit in preventing flare-ups may become evident after several weeks of consistent use.
People taking roflumilast often report mild, temporary symptoms such as:
These effects usually resolve on their own and are not a reason to stop treatment without further advice.
Rare but important reactions can occur, including:
If any of these signs appear, seek urgent medical help.
Roflumilast should be used with care in individuals who have:
Pregnancy and breastfeeding are also situations where the benefits and risks must be weighed carefully, as recommended by the MHRA.
Roflumilast can interact with certain drug groups, for example:
Alcohol consumption may increase the chance of stomach upset. Driving or operating machinery should be approached with caution until you know how the medicine affects you, especially during the first few days of therapy. Detailed interaction lists are provided on the individual product leaflets.
Store roflumilast tablets in a cool, dry place away from direct sunlight and keep them out of reach of children. Treatment duration varies: some people use it for a few months to manage flare-ups, while others may stay on therapy for longer periods under medical supervision. Remember that each tablet brand may have slightly different instructions, so always refer to the specific product information that comes with your medicine.
PDE4 inhibitor: A drug that blocks an enzyme involved in inflammation, helping to reduce swelling in the lungs.
Exacerbation: A sudden worsening of COPD symptoms that often requires extra medication or hospital care.
Inflammation: The body’s response to irritation or injury, which in the lungs can narrow airways and make breathing harder.
This article offers general educational information about roflumilast as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing roflumilast may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
